Balancing Patient Convenience with Environmental Protection

Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection

2018 – A Year When Healthcare in India Got a Booster Shot

2018 has been a happening year for healthcare in India. Developments such as the launch of the government’s flagship universal healthcare program, Ayushman Bharat; the insurance regulator's direction to insurers to cover mental illness; the heightened focus on public screening of non-communicable diseases, all  point to the fact that healthcare is starting to get the … Continue reading 2018 – A Year When Healthcare in India Got a Booster Shot

IHC Public Lecture: Strategic Importance Of Data Sciences In Research And Innovation

DATA IS KING In 2012, IDC projected that the digital universe will reach 40 zettabytes by 2020. This was based on the assumption that 1.7 megabytes of new information will be created every second for every human being on the planet in 2020. IDC realised that its projection was on the conservative side! Its current … Continue reading IHC Public Lecture: Strategic Importance Of Data Sciences In Research And Innovation

2017 – A Landmark Year for Indian Science

By Kiran Mazumdar Shaw, CMD,  Biocon 2017 has been an exciting year for science in India. From unheralded incremental innovations to Big Bang headline-grabbing global feats, Indian scientists have done some very important work to push the frontiers of science during the year. India researchers made significant contributions to R&D across a broad spectrum of … Continue reading 2017 – A Landmark Year for Indian Science

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance

Delivering Affordable Innovation through Scientific Excellence

19th of April is a historic day for India’s space mission. On this day, 42 years ago, ISRO launched the first Indian satellite Aryabhata. Indigenously designed and fabricated in India, Aryabhata was, to paraphrase the legendary Neil Armstrong, “one small step for ISRO, one giant leap for India’s satellite technology.” That India’s maiden satellite was named … Continue reading Delivering Affordable Innovation through Scientific Excellence

CRISPR: A Game Changing Technology for a More Equitable Future

2016 was a landmark year for the biotechnology industry as it was for the first time that the revolutionary CRISPR-Cas9 gene-editing technique was used in humans. With more human trials involving CRISPR-Cas9 scheduled to be conducted, I believe 2017 will be the year when the technology’s potential to treat human diseases could receive strong clinical … Continue reading CRISPR: A Game Changing Technology for a More Equitable Future

Innovation, not price control is the answer to affordable Bt cotton technology

The biggest threat to cotton farmers is the bollworm, because of its ability to cause extraordinary damage to crops and livelihoods. In the 1990s, pesticides were the only weapon farmers had against the bollworm. Half of all the pesticide consumption in India was accounted for by just one crop – cotton. Yet, the ability of … Continue reading Innovation, not price control is the answer to affordable Bt cotton technology

IP Creation Can Make India the Next Global Innovation Hub

In today’s world, technology is playing a transformational role in enabling innovation and driving change. New ideas, new business models and new technologies are leading to the birth of the “ideas economy,” where the “innovation quotient” has emerged as the key determinant of market value. India will lose out on the opportunity to benefit from innovation-led, … Continue reading IP Creation Can Make India the Next Global Innovation Hub

Why FY14 was a Remarkable Year for Biocon

The fiscal year gone by has been one of the most exciting ones for Biocon. We delivered on our promise of affordable innovation, recorded robust top line and bottom line growth, augmented our capacities, optimized our product portfolio and introduced initiatives to achieve operational efficiencies. We successfully commercialized two world-class, low-cost monoclonal antibodies, an outcome … Continue reading Why FY14 was a Remarkable Year for Biocon